TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PeakRemedy AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
336
|
0
![]() |
0 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
2
|
-11
|
-82 |
EBITDA |
2
|
-11
|
-81 |
Total assets |
66
|
216
|
1,461 |
Current assets |
66
|
216
|
1,461 |
Current liabilities |
30
|
0
|
1 |
Equity capital |
37
|
102
|
1,335 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
|
0
|
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.1%
|
47.2%
|
91.4% |
Turnover per employee | 336 | 0 | |
Profit as a percentage of turnover | 0.6% | ||
Return on assets (ROA) |
3.0%
|
-5.1%
|
-5.5% |
Current ratio | 220.0% | 146100% | |
Return on equity (ROE) |
5.4%
|
-10.8%
|
-6.1% |
Change turnover |
336
|
0
|
-3,836 |
Change turnover % | -100% | ||
Chg. No. of employees |
1
|
-1
|
-6 |
Chg. No. of employees % |
-100%
|
-86% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.